A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects
Clinical trial NCT01631942 · TERMINATED
Trial details
- NCT number
- NCT01631942
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-26
- Primary completion
- 2012-09-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.